Lumigan
bimatoprost
Bimatoprost
Keep this leaflet. You may need to read it again.
If you have further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What LUMIGAN 0.1 mg/ml is and what it is used for
What you need to know before you use LUMIGAN 0.1 mg/ml
How to use LUMIGAN 0.1 mg/ml
Possible side effects
How to store LUMIGAN 0.1 mg/ml
Contents of the pack and other information
LUMIGAN is an antiglaucoma preparation. It belongs to a group of medicines called prostamides.
LUMIGAN eye drops are used to reduce high pressure in the eye. This medicine may be used on its own or with other drops called beta-blockers which also reduce pressure.
Your eye contains a clear, watery liquid that feeds the inside of the eye. Liquid is constantly being drained out of the eye and new liquid is made to replace this. If the liquid cannot drain out quickly enough, the pressure inside the eye builds up. This medicine works by increasing the amount of liquid that is drained. This reduces the pressure inside the eye. If the high pressure is not reduced, it could lead to a disease called glaucoma and eventually damage your sight.
if you are allergic to bimatoprost or any of the other ingredients of this medicine (listed in section 6).
if you have had to stop using eye drops in the past because of a side effect of the preservative benzalkonium chloride.
Talk to your doctor or pharmacist before you use LUMIGAN 0.1 mg/ml Talk to your doctor, if:
You have any breathing problems
You have liver or kidney problems
You have had a cataract surgery in the past
You have dry eye
You have or have had any problems with your cornea (front transparent part of the eye)
You wear contact lenses (see “LUMIGAN 0.1 mg/ml contains benzalkonium chloride”)
You have or have had low blood pressure or low heart rate
You have had a viral infection or inflammation of the eye
During treatment, LUMIGAN may cause a loss of fat around the eye, which may cause your eyelid crease to deepen, your eye to appear sunken (enophthalmos), your upper eyelid to droop (ptosis), the skin around your eye to tighten (involution of dermatochalasis) and the lower white part of your eye to become more visible (inferior scleral show). The changes are typically mild, but if pronounced, they can affect your field of vision. The changes may disappear if you stop taking LUMIGAN. LUMIGAN may also cause your eyelashes to darken and grow, and cause the skin around the eyelid to darken too. The colour of your iris may also go darker. These changes may be permanent. The changes may be more noticeable if you are only treating one eye.
LUMIGAN has not been tested in children under the age of 18 and therefore should not be used by patients under 18 years.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
If you are pregnant or breast feeding, think you might be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.
LUMIGAN may get into breast milk so you should not breast-feed while you are taking LUMIGAN.
Your sight may become blurred for a short time just after using LUMIGAN. You should not drive or use machines until your sight is clear again.
This medicine contains 0.6 mg benzalkonium chloride in each 3 ml of solution which is equivalent to
0.2 mg/ml.
Do not use the drops when you are wearing your lenses. A preservative in LUMIGAN, benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and wait 15 minutes after using the drops before you put your lenses back in. Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
LUMIGAN should only be applied to the eye. The recommended dose is one drop of LUMIGAN in the evening, once daily in each eye that needs treatment.
If you use LUMIGAN with another eye medicine, wait at least five minutes between using LUMIGAN and the other eye medicine.
Do not use more than once a day as the effectiveness of treatment may be reduced.
52
You must not use the bottle if the tamper-proof seal on the bottle neck is broken before you first use it.
Wash your hands. Tilt your head back and look at the ceiling.
Gently pull down the lower eyelid until there is a small pocket.
Turn the bottle upside down and squeeze it to release one drop into each eye that needs treatment.
Let go of the lower lid, and close your eye for 30 seconds. Wipe off any excess that runs down the cheek.
If a drop misses your eye, try again.
To help prevent infections and avoid eye injury, do not let the tip of the bottle touch your eye or anything else. Put the cap back on and close the bottle straight after you have used it.
If you use more LUMIGAN than you should, it is unlikely to cause you any serious harm. Put your next dose in at the usual time. If you are worried, talk to your doctor or pharmacist.
If you forget to use LUMIGAN, use a single drop as soon as you remember, and then go back to your regular routine. Do not take a double dose to make up for a forgotten dose.
LUMIGAN should be used every day to work properly. If you stop using LUMIGAN the pressure inside your eye may go up, therefore talk to your doctor before stopping this treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
These may affect one or more users in 10 Affecting the eye
Slight redness (up to 29 % of people)
Loss of fat in the eye region which can lead to deepening of your eyelid crease, sunken eye (enophthalmos), drooping eyelid (ptosis), tightening of the skin around your eye (involution of dermatochalasis), and the lower white part of your eye to become more visible (inferior scleral show)
These may affect 1 to 9 users in 100 Affecting the eye
Small breaks in the surface of the eye, with or without inflammation
Irritation
Itchy eyes
Longer eyelashes
Irritation, when drop is put in the eye
Eye pain
Affecting the skin
Red and itchy eyelids
Darker skin colour around the eye
Hair growth around the eye
These may affect 1 to 9 users in 1000 Affecting the eye
Darker Iris colour
Tired eye
Swelling of the surface of the eye
Blurred vision
Loss of eye lashes
Affecting the skin
Dry skin
Crusting on the edge of the eyelid
Swelling of the eyelid
Itching
Affecting the body
Headache
Feeling of sickness
Affecting the eye
Macular oedema (swelling of the retina at the back of the eye which may lead to worsening vision)
Darker eyelid colour
Dryness
Sticky eyes
A feeling that something is in your eye
Swelling of the eye
Increasing tears
Ocular discomfort
Sensitivity to light
Affecting the body
Asthma
Worsening of asthma
Worsening of the lung disease called chronic obstructive pulmonary disease (COPD)
Shortness of breath
Symptoms of allergic reaction (swelling, redness of the eye and rash of the skin)
Dizziness
Increased blood pressure
Skin discoloration (periocular)
In addition to the side effects for LUMIGAN 0.1 mg/ml, the following side effects have been seen with another medicine containing a higher strength of bimatoprost (0.3 mg/ml):
Ocular burning
An allergic reaction in the eye
Inflamed eyelids
Difficulty in seeing clearly
Worsening of vision
Swelling of the see-through layer that covers the eye
Tears
Darker eyelashes
Retinal bleeding
Inflammation within the eye
Cystoid macular oedema (swelling of the retina within the eye leading to worsening vision)
Eyelid twitching
Eyelid shrinking, moving away from surface of the eye
Skin redness around the eye
Weakness
An increase in blood-test results that show how your liver is working
Other side effects reported with eye drops containing phosphates
In very rare cases, some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of the medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle label and the carton after EXP. The expiry date refers to the last day of that month.
You must throw away the bottle at the latest four weeks after you first opened it, even if there are still some drops left. This will prevent infections. To help you remember, write down the date you opened it in the space on the box.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is bimatoprost. One ml of solution contains 0.1 mg bimatoprost.
The other ingredients are benzalkonium chloride (preservative), sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate and purified water. Small amounts of hydrochloric acid or sodium hydroxide may be added to keep the level of acid (pH levels) normal.
LUMIGAN is a colourless clear eye drop solution in a pack containing either 1 plastic bottle or 3 plastic bottles each with a screw cap. Each bottle is approximately half full and contains 3 millilitres of solution. This is enough for 4 weeks’ usage. Not all pack sizes may be marketed.
67061 Ludwigshafen Deutschland
Allergan Pharmaceuticals Ireland Castlebar Road
Westport Co. Mayo Ireland
For any information about this medicine, please contact the local representative of the marketing authorisation holder.
AbbVie SA
Tél/Tel: +32 10 477811
AbbVie UAB
Tel: + 370 5 205 3023
АбВи ЕООД Тел:+359 2 90 30 430
Tél/Tel: +32 10 477811
AbbVie s.r.o.
Tel.: +420 233 098 111
AbbVie Kft. Tel:+36 1 455 8600
AbbVie A/S
Tlf: +45 72 30 20 28
Vivian Corporation Ltd. Tel: +356 27780331
AbbVie Deutschland GmbH & Co. KG Tel.: 00800 222843 33 (gebührenfrei)
Tel.: +49 (0) 611 / 1720-0
AbbVie B.V.
Tel: +31 (0)88 322 2843
AbbVie OÜ
Tel. +372 6231011
AbbVie AS
Tlf: +47 67 81 80 00
AbbVie ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Τηλ: +30 214 4165 555
AbbVie GmbH Tel: +43 1 20589-0
AbbVie Spain, S.L.U. Tel: +34 913840910
AbbVie Sp. z o.o.
Tel.: +48 22 372 78 00
AbbVie
Tél: +33 (0) 1 45 60 13 00
AbbVie, Lda.
Tel.: +351 (0)21 1908400
AbbVie d.o.o.
Tel: + 385 (0)1 5625 501
AbbVie S.R.L.
Tel: +40 21 529 30 35
AbbVie Limited
Tel: +353 (0)1 4287900
AbbVie Biofarmacevtska družba d.o.o. Tel: +386 (1)32 08 060
Vistor hf.
Sími: +354 535 7000
AbbVie s.r.o.
Tel: +421 2 5050 0777
AbbVie S.r.l.
Tel: +39 06 928921
AbbVie Oy
Puh/Tel: +358 (0)10 2411 200
Lifepharma (Z.A.M.) Ltd Τηλ: +357 22 34 74 40
AbbVie AB
Tel: +46 (0)8 684 44 600
AbbVie SIA
Tel: +371 67605000
Detailed information on this medicinal product is available on the European Medicines Agency web site: .